Plasma products - Clinical trials 

  • Clinical trials

Clinical trials for Plasma products

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Plasma products. For all clinical trials, go to clinical trials search

This list shows clinical trials for Plasma products

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Plasma products
  • 1 - 7 of 7
Title Recruitment status Location
A comparative, open-label, randomised, cross-over phase I trial in healthy volunteers to investigate the relative efficacy, safety and tolerability of OctaplasLG™ versus Octaplas® SD Not recruiting Austria
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients. Estudio de escalada de dosis para evaluar la farmacocinÊtica, la eficacia y la seguridad de apotransferrina, en pacientes con atransferrinemia. - Apotransferrin replacement in atransferrinemia Authorised Germany
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients. Estudio de escalada de dosis para evaluar la farmacocinÊtica, la eficacia y la seguridad de apotransferrina, en pacientes con atransferrinemia. - Apotransferrin replacement in atransferrinemia Authorised Spain
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients - Apotransferrin replacement in atransferrinemia Authorised Germany
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients - Apotransferrin replacement in atransferrinemia Authorised Spain
Treatment in patients with recurrent infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response. - Treatment of IgG Subclass Deficiency and/or Deficiency of Anti-Polysaccharide Antibody Response Authorised Netherlands
Controlled trail of immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial parvovirus B19 persistence - - a prospective, double-blind, randomized, placebo-controlled clinical trial. - IVIg for PVB19 mediated cardiomyopathy Authorised Netherlands
  • 1 - 7 of 7
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member